Shares of Maiden Holdings, Ltd. (NASDAQ:MHLD) have earned an average recommendation of “Hold” from the seven ratings firms that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $6.00.
A number of research analysts have commented on MHLD shares. ValuEngine upgraded Maiden from a “hold” rating to a “buy” rating in a research report on Thursday. BidaskClub upgraded Maiden from a “hold” rating to a “buy” rating in a research report on Saturday, July 21st. TheStreet lowered Maiden from a “c-” rating to a “d+” rating in a research report on Friday, August 17th. Keefe, Bruyette & Woods reiterated a “market perform” rating on shares of Maiden in a research report on Tuesday, October 9th. They noted that the move was a valuation call. Finally, B. Riley decreased their price objective on Maiden from $8.00 to $4.00 and set a “neutral” rating on the stock in a research report on Thursday, September 6th.
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Salzhauer Michael boosted its position in shares of Maiden by 82.5% in the 3rd quarter. Salzhauer Michael now owns 157,641 shares of the insurance provider’s stock worth $438,000 after purchasing an additional 71,248 shares during the last quarter. Nwam LLC boosted its position in shares of Maiden by 70.2% in the 3rd quarter. Nwam LLC now owns 76,471 shares of the insurance provider’s stock worth $218,000 after purchasing an additional 31,550 shares during the last quarter. Global X Management Co LLC bought a new position in shares of Maiden in the 2nd quarter worth $7,783,000. PVG Asset Management Corp bought a new position in shares of Maiden in the 2nd quarter worth $616,000. Finally, MetLife Investment Advisors LLC boosted its position in shares of Maiden by 95.8% in the 2nd quarter. MetLife Investment Advisors LLC now owns 32,906 shares of the insurance provider’s stock worth $255,000 after purchasing an additional 16,103 shares during the last quarter. Hedge funds and other institutional investors own 62.05% of the company’s stock.
MHLD traded down $0.15 during mid-day trading on Monday, reaching $3.63. The stock had a trading volume of 501,357 shares, compared to its average volume of 681,420. The firm has a market capitalization of $314.28 million, a price-to-earnings ratio of -1.68 and a beta of 0.66. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.15 and a current ratio of 0.15. Maiden has a 52 week low of $2.15 and a 52 week high of $9.10.
Maiden (NASDAQ:MHLD) last announced its quarterly earnings data on Thursday, August 9th. The insurance provider reported ($0.13) EPS for the quarter, missing the Zacks’ consensus estimate of $0.26 by ($0.39). The firm had revenue of $713.69 million during the quarter. Maiden had a negative net margin of 5.43% and a negative return on equity of 21.35%. As a group, research analysts forecast that Maiden will post 1.1 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, October 15th. Shareholders of record on Monday, October 1st were given a $0.05 dividend. The ex-dividend date was Friday, September 28th. This represents a $0.20 dividend on an annualized basis and a yield of 5.51%. Maiden’s payout ratio is -9.26%.
Maiden Company Profile
Maiden Holdings, Ltd., through its subsidiaries, provides reinsurance solutions to regional and specialty insurers in the United States, Europe, and internationally. It operates in two segments, Diversified Reinsurance and AmTrust Reinsurance. The Diversified Reinsurance segment offers property and casualty reinsurance, including the writing of treaties on a quota share or excess of loss basis; and facultative risks, which are marketed through third-party intermediaries and on a direct basis.
Further Reading: Trading Strategy Methods for Individual Investors
Receive News & Ratings for Maiden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maiden and related companies with MarketBeat.com's FREE daily email newsletter.